Development of a Plant-Expressed Subunit Vaccine against Brucellosis
Microorganisms · 22.05.2024 · 12 (6) · 1047
DOI: 10.3390/microorganisms12061047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 22.05.2024. Verfasst von Daria A Rutkowska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Agriculture and Food Cluster, Council for Scientific and Industrial Research, Pretoria 0001, South Africa. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Global Alliance for Livestock Veterinary Medicines, SmartBiotech (Pty) Ltd., Galvmed.
Abstract (Originalsprache)
Brucellosis is an important bacterial disease of livestock and the most common zoonotic disease. The current vaccines are effective but unsafe, as they result in animal abortions and are pathogenic to humans. Virus-like particles are being investigated as molecular scaffolds for foreign antigen presentation to the immune system. Here, we sought to develop a new-generation vaccine by presenting selected Brucella melitensis T cell epitopes on the surface of Orbivirus core-like particles (CLPs) and transiently expressing these chimeric particles in Nicotiana benthamiana plants. We successfully demonstrated the assembly of five chimeric CLPs in N. benthamiana plants, with each CLP presenting a different T cell epitope. The safety and protective efficacy of three of the highest-yielding CLPs was investigated in a mouse model of brucellosis. All three plant-expressed chimeric CLPs were safe when inoculated into BALB/c mice at specific antigen doses. However, only one chimeric CLP induced protection against the virulent Brucella strain challenge equivalent to the protection induced by the commercial Rev1 vaccine. Here, we have successfully shown the assembly, safety and protective efficacy of plant-expressed chimeric CLPs presenting B. melitensis T cell epitopes. This is the first step in the development of a safe and efficacious subunit vaccine against brucellosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Advanced Agriculture and Food Cluster, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
- Centre of Excellence for Pharmaceutical Sciences (PharmacenTM), North-West University, Potchefstroom 2520, South Africa.
- Future Production and Chemicals Cluster, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
- Synthetic Biology and Precision Medicine Centre, Future Production and Chemicals Cluster, Council for Scientific and Industrial Research, Pretoria 0001, South Africa.
ORCID-Profile: Daria A Rutkowska, Lissinda H Du Plessis, Essa Suleman, Martha M O'Kennedy, Deepak B Thimiri Govinda Raj, Yolandy Lemmer
Förderung
- Global Alliance for Livestock Veterinary Medicines
- SmartBiotech (Pty) Ltd.
- Galvmed
- CSIR internal Parliamentary
Zitieren
APA
Rutkowska, D. A., Du Plessis, L. H., Suleman, E., O'Kennedy, M. M., Thimiri Govinda Raj, D. B., & Lemmer, Y. (2024). Development of a Plant-Expressed Subunit Vaccine against Brucellosis. Microorganisms, 12(6), 1047. https://doi.org/10.3390/microorganisms12061047
Vancouver
Rutkowska DA, Du Plessis LH, Suleman E, O'Kennedy MM, Thimiri Govinda Raj DB, Lemmer Y. Development of a Plant-Expressed Subunit Vaccine against Brucellosis. Microorganisms. 2024;12(6):1047. doi:10.3390/microorganisms12061047
BibTeX
@article{Rutkowska2024,
author = {Rutkowska, Daria A and Du Plessis, Lissinda H and Suleman, Essa and O'Kennedy, Martha M and Thimiri Govinda Raj, Deepak B and Lemmer, Yolandy},
title = {Development of a Plant-Expressed Subunit Vaccine against Brucellosis},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {6},
pages = {1047},
doi = {10.3390/microorganisms12061047}
}
EUVIMED